Association of white blood cell count with systolic blood pressure within the normotensive range
- 2 March 2006
- journal article
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 20 (5), 341-347
- https://doi.org/10.1038/sj.jhh.1001992
Abstract
Hypertension and inflammation promote cardiovascular disease (CVD). Even high normal systolic blood pressure (SBP) is associated with increased CVD risk. We assessed the relationship of elevated SBP within the normotensive range and white blood cell (WBC) count. This is a cross-sectional study of 3484 white asymptomatic individuals (mean age: 43+/-8 years, 79% males) without hypertension with SBPor=75th percentile (8.35 x 10(9) cells/l) was considered cutoff for elevated WBC. Subjects were classified into three levels of SBP (first: <120 mm Hg, n=1,176, 34%; second: 120-129 mm Hg, n=1,654, 47%; third: 130-139 mm Hg, n=654, 19%). Mean WBC count increased linearly across SBP categories (first: 6.14+/-1.54, second: 6.20+/-1.52, third: 6.41+/-1.62, P=0.02 for trend). There was a linear increase in prevalence of elevated WBC across higher SBP categories (22, 24 and 28%, P=0.02). As compared to those with SBP<120 mm Hg, in multivariate linear regression analyses (adjusting for age, gender, smoking status, diabetes, body mass index, physical activity, cholesterol/high-density lipoprotein cholesterol ratio) WBC count was significantly higher among participants with SBP 130-139 mm Hg (regression coefficient: 2.64, 95% confidence interval: 1.04-4.24, P=0.001). Odds ratio for prevalence of elevated WBC with SBP<120 mm Hg as reference group was 1.14 (0.92-1.41) for SBP 120-129 mm Hg and 1.50 (1.15-1.92) for SBP 130-139 mm Hg. In conclusion, Higher SBP within the normotensive range is also associated with elevated WBC count. Further studies are needed to clarify the role of inflammation in high normal SBP and associated CVD risk.This publication has 44 references indexed in Scilit:
- Recommendations for Blood Pressure Measurement in Humans and Experimental AnimalsHypertension, 2005
- Broadly Altered Gene Expression in Blood Leukocytes in Essential Hypertension Is Absent During TreatmentHypertension, 2004
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Do leukocytes have a role in hypertension?Hypertension, 1991
- Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevanceJournal of the American College of Cardiology, 1990
- Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarctionJournal of the American College of Cardiology, 1990
- Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patientsBiochemical and Biophysical Research Communications, 1989
- Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusionJournal of the American College of Cardiology, 1988
- The Pathogenesis of Atherosclerosis — An UpdateThe New England Journal of Medicine, 1986
- Leukocyte Count, Smoking, and Myocardial InfarctionThe New England Journal of Medicine, 1981